| AMUNDI FUNDS US EQUITY RESEARCH VALUE R2 EUR (C) | RVI USA VALOR | 116,930000 | 02/11/2026 | 24,77% | 57,69% | ** |
| MAN SYSTEMATIC EMERGING MARKETS EQUITY IX NOK | RVI EMERGENTES | 12,862605 | 30/10/2026 | 24,77% | · | ND |
| ROBECO QI EMERGING CONSERVATIVE EQUITIES I USD | RVI EMERGENTES | 211,082382 | 02/11/2026 | 24,77% | 61,26% | * |
| SCHRODER ISF GLOBAL EQUITY YIELD I ACC EUR | RVI GLOBAL VALOR | 471,099400 | 02/11/2026 | 24,77% | 65,03% | *** |
| STATE STREET EMERGING MARKETS SCREENED ENHANCED EQUITY FUND P EUR CAP | RVI EMERGENTES | 20,019300 | 02/11/2026 | 24,77% | 82,11% | **** |
| JUPITER SYSTEMATIC HEALTHCARE INNOVATION FUND I GBP CAP | RVI SALUD | 15,579804 | 02/11/2026 | 24,76% | · | ND |
| ROBECO BP US LARGE CAP EQUITIES F USD | RVI USA | 387,286020 | 02/11/2026 | 24,76% | 66,43% | ** |
| SPARINVEST - GLOBAL VALUE EUR I CAP | RVI GLOBAL VALOR | 771,910000 | 02/11/2026 | 24,76% | 76,90% | **** |
| MFS MERIDIAN EMERGING MARKETS EQUITY RESEARCH FUND I1-EUR | RVI EMERGENTES | 146,980000 | 02/11/2026 | 24,75% | 69,86% | *** |
| ROBECO BP US PREMIUM EQUITIES I EUR | RVI USA VALOR | 846,810000 | 02/11/2026 | 24,75% | 58,71% | **** |
